FIELD: medicine, cardiology in particular.
SUBSTANCE: invention relates to medicine, namely to therapy and cardiology, and deals with the prediction of the effectiveness of renal denervation in patients with arterial hypertension resistant to drug therapy. To do this, the developed formula is used to calculate the value of “p” taking into account the following indicators: age, transverse size of the cisterna prepontinis, transverse size of the quadrigeminal cistern, length of the III ventricle, transverse size of the IV ventricle, systolic and diastolic blood pressure, the presence of lacunae, the presence of lacunae in the II region. At a value of p<0.5, the ineffectiveness of the procedure is predicted and it is considered impractical, and at a value of p < 0.5, the effectiveness of the procedure is confirmed and prescribed to the patient.
EFFECT: method provides an increase in the accuracy of the prognosis for the antihypertensive effectiveness of sympathetic denervation, which, in turn, reduces the unjustified risk of complications from this procedure in patients with a low probability of an effective response.
1 cl, 2 ex
| Title | Year | Author | Number |
|---|---|---|---|
| METHOD FOR PREDICTING THE EFFECTIVENESS OF THE PROCEDURE OF SYMPATHETIC RENAL DENERVATION OF RENAL ARTERIES IN PATIENTS WITH RESISTANT ARTERIAL HYPERTENSION COMBINED WITH TYPE 2 DIABETES MELLITUS | 2021 |
|
RU2772544C1 |
| METHOD OF ESTIMATING DEGREE OF HYPERTONIC ANGIOENCEPHALOPATHY IN PATIENT WITH ESSENTIAL HYPERTENSION | 2009 |
|
RU2421131C1 |
| METHOD FOR PREDICTION OF IMPROVEMENT OF LEFT VENTRICULAR DIASTOLIC FUNCTION IN 6 MONTHS AFTER PROCEDURE OF SYMPATHETIC DENERVATION OF RENAL ARTERIES IN PATIENTS WITH RESISTANT ARTERIAL HYPERTENSION COMBINED WITH TYPE 2 DIABETES MELLITUS | 2023 |
|
RU2817191C1 |
| METHOD OF SELECTION OF PATIENTS WITH RESISTANT ARTERIAL HYPERTENSION FOR CONDUCTING THE PROCEDURE OF SYMPATHETIC DENERVATION OF RENAL ARTERIES | 2017 |
|
RU2658476C1 |
| METHOD OF SELECTING PATIENTS WITH RESISTANT HYPERTENSION YOUNGER THAN 60 YEARS WITH DISTURBED CEREBRAL BLOOD FLOW RESERVE FOR SAFE AND EFFECTIVE TREATMENT BY RENAL DENERVATION | 2018 |
|
RU2687009C1 |
| METHOD FOR PREDICTING IMPROVEMENT OF RENAL HEMODYNAMICS 6 MONTHS AFTER PROCEDURE OF SYMPATHETIC DENERVATION OF RENAL ARTERIES IN PATIENTS WITH RESISTANT ARTERIAL HYPERTENSION COMBINED WITH TYPE 2 DIABETES MELLITUS | 2023 |
|
RU2807270C1 |
| METHOD FOR PREDICTING THE EFFECTIVENESS OF NEPHROPROTECTION IN SELECTING THE PATIENTS WITH RESISTANT ARTERIAL HYPERTENSION ASSOCIATED WITH TYPE 2 DIABETES MELLITUS FOR THE SYMPATHETIC RENAL DENERVATION OF RENAL ARTERIES | 2019 |
|
RU2728093C1 |
| METHOD FOR PREDICTING ARTERIAL HYPERTENSION VARIANT IN ELDERLY AND SENILE PATIENTS | 2003 |
|
RU2266702C2 |
| METHOD FOR SELECTING PATIENTS SUFFERING FROM DRUG-RESISTANT ARTERIAL HYPERTENSION FOR PERFORMING RENAL SYMPATHETIC DENERVATION | 2014 |
|
RU2563449C1 |
| METHOD FOR PREDICTING THE LONG-TERM ANTIHYPERTENSIVE EFFICACY OF RENAL DENERVATION IN PATIENTS WITH RESISTANT ARTERIAL HYPERTENSION | 2021 |
|
RU2767134C1 |
